AB-005

Quality 0.50 · 0 views · Updated 2 months ago

Group of stereoisomers

title: "AB-005" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["cannabinoids", "designer-drugs", "tetramethylcyclopropanoylindoles", "piperidines"] description: "Group of stereoisomers" topic_path: "general/cannabinoids" source: "https://en.wikipedia.org/wiki/AB-005" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0

::summary Group of stereoisomers ::

| Verifiedfields = | verifiedrevid = | IUPAC_name = 1-[(1-Methylpiperidin-2-yl)methyl]-1H-indol-3-yl-methanone | image = AB-005.png | image_class = skin-invert-image | width = 200

| tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = Schedule II | legal_DE = NpSG | legal_UK = Class B | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number_Ref = | CAS_number = 895155-25-6 | UNII_Ref = | UNII = TPY5M47AYQ | ATC_prefix = | ATC_suffix = | PubChem = 11537652 | DrugBank_Ref = | DrugBank = | ChemSpiderID_Ref = | ChemSpiderID = 9712433 | ChEMBL = 571330

| C=23 | H=32 | N=2 | O=1 | smiles = CC1(C(C1(C)C)C(=O)C2=CN(C3=CC=CC=C32)CC4CCCCN4C)C | StdInChI = 1S/C23H32N2O/c1-22(2)21(23(22,3)4)20(26)18-15-25(19-12-7-6-11-17(18)19)14-16-10-8-9-13-24(16)5/h6-7,11-12,15-16,21H,8-10,13-14H2,1-5H3 | StdInChIKey = MOBWRRIAIHYXLB-UHFFFAOYSA-N

AB-005 or 1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl-methanone is a designer drug offered by online vendors as a cannabimimetic agent. The structure and pharmacological activity of AB-005 was published in 2010, prior to its commercial availability in 2012, where it was reported to have high affinity for both CB1 (Ki = 5.5 nM) and CB2 receptors (Ki = 0.48 nM). AB-005 features groups found in other previously reported synthetic cannabinoids: the tetramethylcyclopropane group of UR-144 and XLR-11 as well as the (1-methyl-2-piperidinyl)methyl substituent of AM-1248 and AM-1220. No information regarding the in vivo activity of AB-005 has been published, and only anecdotal reports are known of its psychoactivity in humans.

Legal status

In 2013, psychoactive products in New Zealand containing this drug were given interim approval under psychoactive substances legislation.

References

References

  1. "Interim Product Approvals". [[Ministry of Health (New Zealand).

::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::

cannabinoidsdesigner-drugstetramethylcyclopropanoylindolespiperidines